Esaote Unveils New Imaging Portfolio

Esaote's latest systems are tailored for the expanding field of interventional radiology, with the MyLab E85 and C30 GTS Edition ultrasounds designed to support guided procedures and therapies. The technology focuses on enhancing needle visualization and providing real-time multimodality fusion imaging, aiming to make ultrasound a stronger partner to CT-guided interventions. On the MRI front, the company is embedding artificial intelligence to tackle operational efficiency. Its new HyperSpeed AI module is engineered to shorten MRI scan times, a critical factor for increasing patient throughput, while a new M-Score software allows for bone-health assessment during routine spine exams. This follows a trend of manufacturers leveraging AI to boost image quality and reduce scan times, with some platforms promising up to a 60% reduction. This product launch comes as outpatient imaging volume is projected to grow significantly, with advanced modalities like CT, PET, and ultrasound expected to increase by 14-23% over the next decade. However, this growth is set against a backdrop of declining reimbursements. In 2025, CMS implemented a 2.9% average payment rate decrease for physicians, including radiologists, continuing a multi-year trend of cuts to diagnostic services. The shift to outpatient settings is a major strategic focus for health systems, which are increasingly looking to expand their freestanding imaging footprint through acquisitions, joint ventures, or building new facilities. This is partly a response to commercial payers adopting site-neutral payment policies that reduce the financial advantages of hospital-based imaging. This market shift has fueled consolidation among imaging providers, with the median size of the top 100 private radiology practices growing to stay competitive. For mobile imaging providers, the competitive landscape includes established companies like RAYUS Radiology, DMS Health, and Akumin Inc., who are expanding their reach through partnerships and acquisitions. The U.S. mobile and fixed imaging market was valued at $102.4 billion in 2024 and is expected to grow, driven by an aging population and the demand for point-of-care diagnostics. Radiology directors are currently grappling with significant staffing shortages and operational efficiency pressures. The integration of AI into workflows is a key topic, with hundreds of AI tools now having received FDA clearance for medical imaging. These tools are being adopted to assist with tasks like workflow triage, flagging urgent cases, and automating exam protocols to alleviate workforce constraints.